Vitrolife AB (STU:VTFN)
ā‚¬ 18.72 -0.32 (-1.68%) Market Cap: 2.57 Bil Enterprise Value: 2.67 Bil PE Ratio: 0 PB Ratio: 2.25 GF Score: 87/100

Q1 2022 Vitrolife AB Earnings Call Transcript

Apr 22, 2022 / 08:00AM GMT
Release Date Price: ā‚¬26.48 (-10.30%)
Operator

Good day, and thank you for standing by. Welcome to the interim report January to March 2022. (Operator Instructions) I must advise you that today's conference is being recorded. I would now like to hand the conference over to our speaker today, Mr. Thomas Axelsson. Thank you, and please go ahead.

Thomas Axelsson;publ;President;CEO
Vitrolife AB

()-&

Thank you very much, and welcome to Vitrolife Interim Report January-March 2022. The speakers of today will be the CFO of the company, Patrik Tolf; and myself, Thomas Axelsson, and I am the CEO of the company. Please go to Page #2, so we can look through this report.

This is the first quarter that we have done within the Vitrolife group, the combination of the service business within the genetic field and the device business from, let's say, the earlier Vitrolife. What we are doing and the ambition between this group is to continue to have good, good growth, and a good momentum is what we can see in this quarter.

We will go through in this

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investorsā€™ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot